Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology phase 3 results impossible for TLT to beat?

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jan 25, 2024 12:14am

162 Views

Post# 35844389

RE:RE:RE:RE:CG Oncology phase 3 results impossible for TLT to beat?

They have a phase 3 standalone trial and a phase 2 combo with Keytruda.

livermore2 wrote: It's a combo treatment with Keytruda we are currently a standalone. This IPO may bring some eyes on us to show what kind of valuation a bladder treatment warrants.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals